Cargando…

ERDO - a framework to select an appropriate randomization procedure for clinical trials

BACKGROUND: Randomization is considered to be a key feature to protect against bias in randomized clinical trials. Randomization induces comparability with respect to known and unknown covariates, mitigates selection bias, and provides a basis for inference. Although various randomization procedures...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilgers, Ralf-Dieter, Uschner, Diane, Rosenberger, William F., Heussen, Nicole
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715815/
https://www.ncbi.nlm.nih.gov/pubmed/29202708
http://dx.doi.org/10.1186/s12874-017-0428-z
_version_ 1783283828196900864
author Hilgers, Ralf-Dieter
Uschner, Diane
Rosenberger, William F.
Heussen, Nicole
author_facet Hilgers, Ralf-Dieter
Uschner, Diane
Rosenberger, William F.
Heussen, Nicole
author_sort Hilgers, Ralf-Dieter
collection PubMed
description BACKGROUND: Randomization is considered to be a key feature to protect against bias in randomized clinical trials. Randomization induces comparability with respect to known and unknown covariates, mitigates selection bias, and provides a basis for inference. Although various randomization procedures have been proposed, no single procedure performs uniformly best. In the design phase of a clinical trial, the scientist has to decide which randomization procedure to use, taking into account the practical setting of the trial with respect to the potential of bias. Less emphasis has been placed on this important design decision than on analysis, and less support has been available to guide the scientist in making this decision. METHODS: We propose a framework that weights the properties of the randomization procedure with respect to practical needs of the research question to be answered by the clinical trial. In particular, the framework assesses the impact of chronological and selection bias on the probability of a type I error. The framework is applied to a case study with a 2-arm parallel group, single center randomized clinical trial with continuous endpoint, with no-interim analysis, 1:1 allocation and no adaptation in the randomization process. RESULTS: In so doing, we derive scientific arguments for the selection of an appropriate randomization procedure and develop a template which is illustrated in parallel by a case study. Possible extensions are discussed. CONCLUSION: The proposed ERDO framework guides the investigator through a template for the choice of a randomization procedure, and provides easy to use tools for the assessment. The barriers for the thorough reporting and assessment of randomization procedures could be further reduced in the future when regulators and pharmaceutical companies employ similar, standardized frameworks for the choice of a randomization procedure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-017-0428-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5715815
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57158152017-12-08 ERDO - a framework to select an appropriate randomization procedure for clinical trials Hilgers, Ralf-Dieter Uschner, Diane Rosenberger, William F. Heussen, Nicole BMC Med Res Methodol Technical Advance BACKGROUND: Randomization is considered to be a key feature to protect against bias in randomized clinical trials. Randomization induces comparability with respect to known and unknown covariates, mitigates selection bias, and provides a basis for inference. Although various randomization procedures have been proposed, no single procedure performs uniformly best. In the design phase of a clinical trial, the scientist has to decide which randomization procedure to use, taking into account the practical setting of the trial with respect to the potential of bias. Less emphasis has been placed on this important design decision than on analysis, and less support has been available to guide the scientist in making this decision. METHODS: We propose a framework that weights the properties of the randomization procedure with respect to practical needs of the research question to be answered by the clinical trial. In particular, the framework assesses the impact of chronological and selection bias on the probability of a type I error. The framework is applied to a case study with a 2-arm parallel group, single center randomized clinical trial with continuous endpoint, with no-interim analysis, 1:1 allocation and no adaptation in the randomization process. RESULTS: In so doing, we derive scientific arguments for the selection of an appropriate randomization procedure and develop a template which is illustrated in parallel by a case study. Possible extensions are discussed. CONCLUSION: The proposed ERDO framework guides the investigator through a template for the choice of a randomization procedure, and provides easy to use tools for the assessment. The barriers for the thorough reporting and assessment of randomization procedures could be further reduced in the future when regulators and pharmaceutical companies employ similar, standardized frameworks for the choice of a randomization procedure. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-017-0428-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-12-04 /pmc/articles/PMC5715815/ /pubmed/29202708 http://dx.doi.org/10.1186/s12874-017-0428-z Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Technical Advance
Hilgers, Ralf-Dieter
Uschner, Diane
Rosenberger, William F.
Heussen, Nicole
ERDO - a framework to select an appropriate randomization procedure for clinical trials
title ERDO - a framework to select an appropriate randomization procedure for clinical trials
title_full ERDO - a framework to select an appropriate randomization procedure for clinical trials
title_fullStr ERDO - a framework to select an appropriate randomization procedure for clinical trials
title_full_unstemmed ERDO - a framework to select an appropriate randomization procedure for clinical trials
title_short ERDO - a framework to select an appropriate randomization procedure for clinical trials
title_sort erdo - a framework to select an appropriate randomization procedure for clinical trials
topic Technical Advance
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715815/
https://www.ncbi.nlm.nih.gov/pubmed/29202708
http://dx.doi.org/10.1186/s12874-017-0428-z
work_keys_str_mv AT hilgersralfdieter erdoaframeworktoselectanappropriaterandomizationprocedureforclinicaltrials
AT uschnerdiane erdoaframeworktoselectanappropriaterandomizationprocedureforclinicaltrials
AT rosenbergerwilliamf erdoaframeworktoselectanappropriaterandomizationprocedureforclinicaltrials
AT heussennicole erdoaframeworktoselectanappropriaterandomizationprocedureforclinicaltrials